Double Feature: PD-L1 Interpretation in Esophageal Cancer and Cervical Cancer

The Precision Pathology Insights webinar series provides expert insight into the methods used to efficiently and accurately determine Combined Positive Score (CPS), helping elevate your confidence in PD-L1 evaluation. 
 

This double feature webinar is presented by two distinguished experts in the field of pathology, Prof. Dr. Dr. Jens Neumann and Dr. Kristopher Kersch. The webinar is moderated by Greg Harlow, PhD, a Senior Medical Affairs Consultant at Agilent. Recorded on 16 November 2022. ​

Prof. Dr. Dr. Jens Neumann speaks on “PD-L1 Immunostaining in Esophageal Cancer – Pitfalls and Pearls Associated with Current Scores” while Dr. Kristopher Kersch makes a review of “Cervical Cancer – A Tale of Two Histologies.” 

Dr. Neumann and Dr. Kersch will present:​

• An overview of the current PD-L1 testing environment​
• Deep-dives into the nuances and challenges of PD-L1 interpretation in Esophageal and Cervical Cancer respectively​
• Indication-specific PD-L1 staining characteristics and morphological features that impact CPS evaluation​
• Real-world case walkthroughs and scoring examples​

This website addresses general principles for CDx scoring and is for education purposes only. Not all cancer indications mentioned are approved worldwide. Please refer to local Instructions for Use for further details.​D0113752_1.00